The effect of leucocyte depletion on the quality of fresh-frozen plasma

British Journal of Haematology

Volumn 114, Issue 1, 2001, Pages 233-240

  Cardigan, R ^a   Sutherland, J ^a   Garwood, M ^a   Krailadsiri, P ^a   Seghatchian, J ^a   Beard, M ^a   Beckman, N ^a   Williamson, L M ^a,b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Coagulation; Leucodepletion; Plasma; Quality; Transfusion

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; COMPLEMENT COMPONENT C3A; FRESH FROZEN PLASMA; PROTHROMBIN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD CLOTTING; BLOOD FILTER; BLOOD TRANSFUSION; COMPLEMENT ACTIVATION; HUMAN; LEUKOCYTE; PLASMA; PRIORITY JOURNAL; QUALITY CONTROL; SURFACE CHARGE; THROMBOCYTE;

BLOOD COAGULATION FACTORS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HEMOFILTRATION; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MICROPORE FILTERS; PLASMA; PLATELET COUNT; STATISTICS, NONPARAMETRIC; VON WILLEBRAND FACTOR;

EID: 0034940320     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02907.x     Document Type: Article

References (33)

1. Factor VIII/von willebrand factor complex in methylene blue-treated fresh plasma
2. Guidelines for the use of fresh frozen plasma
3. Guidelines on the clinical use of leucocyte depleted blood components
4. Bradykinin stimulates tissue plasminogen activator release in human vasculature
5. Activation of plasminogen by human plasma kallikrein
6. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor
7. Stabilisation of von Willebrand factor in banked blood by leucocyte depletion
8. Removal of anaphylotoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters
9. Activation of the classical pathway of complement by Hageman factor fragment
10. The activation of plasminogen by Hageman factor (factor XII) and Hageman factor fragments
11. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma
12. In vitro and in vivo evaluation of cotton wool filtration of platelet concentrates obtained by automated and manual apheresis
13. Hypotensive reactions: A previously uncharacterised complication of platelet transfusion?
14. Activation of the complement system at the interface between blood and artificial surfaces
15. Photoinactivation of viruses in human flesh plasma by phenothiazine dyes in combination with visible light
16. Phast assessment of vWF: Ag multimeric distribution
17. Application of a time resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components
18. Proteolysis of von Willebrand factor in therapeutic plasma concentrates
19. Preliminary assessment of whole-blood, red cell and platelet leucodepleting filters for possible induction of prion release by leucocyte fragmentation during room temperature processing
20. Possibility to improve preservation of whole blood by leukocyte-depletion before storage
21. Prestorage inline filtration of whole blood for obtaining white cell-reduced blood components
22. Interaction of blood with artificial surfaces
23. Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters
24. Adsorption of anaphylotoxins and platelet-specific proteins by filtration of platelet concentrates with a polyester leucocyte reduction filter
25. Removal of soluble biologic response modifiers (complement and chemokines) by a bedside white cell-reduction filter
26. Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders
27. Human plasma kallikrein releases neutrophil elastase during blood coagulation
28. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation
29. Contamination of fresh-frozen plasma with viable white cells and proliferable stem cells
30. Chemotactic activity generated by the fifth component of complement by plasma kallikrein of the rabbit
31. Evaluation of plasma and red cells obtained after leucocyte depletion of whole blood
32. White cells in fresh-frozen plasma: Evaluation of a new white cell-reduction filter